Sumitomo Life Insurance Co. trimmed its holdings in shares of Teradyne, Inc. (NASDAQ:TER – Get Rating) by 6.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,797 shares of the company’s stock after selling 343 shares during the period. Sumitomo Life Insurance Co.’s holdings in Teradyne were worth $419,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently bought and sold shares of the business. Empirical Finance LLC lifted its holdings in shares of Teradyne by 23.1% in the 3rd quarter. Empirical Finance LLC now owns 3,443 shares of the company’s stock valued at $259,000 after purchasing an additional 647 shares during the last quarter. First Trust Advisors LP lifted its holdings in shares of Teradyne by 43.5% in the 3rd quarter. First Trust Advisors LP now owns 181,170 shares of the company’s stock valued at $13,614,000 after purchasing an additional 54,930 shares during the last quarter. Barclays PLC lifted its holdings in shares of Teradyne by 24.8% in the 3rd quarter. Barclays PLC now owns 678,473 shares of the company’s stock valued at $50,987,000 after purchasing an additional 134,867 shares during the last quarter. Hartford Investment Management Co. lifted its holdings in shares of Teradyne by 7.7% in the 3rd quarter. Hartford Investment Management Co. now owns 25,506 shares of the company’s stock valued at $1,917,000 after purchasing an additional 1,832 shares during the last quarter. Finally, Boothbay Fund Management LLC purchased a new stake in shares of Teradyne in the 3rd quarter valued at about $601,000. 97.05% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Teradyne
In related news, VP Charles Jeffrey Gray sold 686 shares of the company’s stock in a transaction that occurred on Tuesday, January 31st. The stock was sold at an average price of $100.00, for a total value of $68,600.00. Following the sale, the vice president now owns 23,270 shares of the company’s stock, valued at approximately $2,327,000. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Teradyne news, insider Brad Robbins sold 2,710 shares of the stock in a transaction on Monday, January 23rd. The stock was sold at an average price of $100.00, for a total transaction of $271,000.00. Following the transaction, the insider now owns 44,898 shares of the company’s stock, valued at approximately $4,489,800. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Charles Jeffrey Gray sold 686 shares of the stock in a transaction on Tuesday, January 31st. The stock was sold at an average price of $100.00, for a total value of $68,600.00. Following the transaction, the vice president now directly owns 23,270 shares in the company, valued at approximately $2,327,000. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,216 shares of company stock valued at $1,527,578. 0.36% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Several analysts have recently weighed in on the company. Jefferies Financial Group assumed coverage on Teradyne in a report on Thursday, January 12th. They issued a “buy” rating for the company. Loop Capital cut Teradyne from a “buy” rating to a “hold” rating and dropped their price target for the company from $110.00 to $102.00 in a research report on Friday, January 27th. KeyCorp boosted their price target on Teradyne from $110.00 to $117.00 and gave the company an “overweight” rating in a research report on Friday. Morgan Stanley boosted their price target on Teradyne from $92.00 to $101.00 and gave the company an “equal weight” rating in a research report on Friday, January 27th. Finally, Citigroup boosted their price target on Teradyne from $112.00 to $125.00 and gave the company a “buy” rating in a research report on Sunday, February 5th. Ten research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, Teradyne presently has a consensus rating of “Moderate Buy” and an average target price of $87.38.
Teradyne Price Performance
Shares of NASDAQ:TER opened at $106.34 on Friday. The business’s 50 day simple moving average is $103.63 and its 200-day simple moving average is $91.30. The firm has a market capitalization of $16.59 billion, a price-to-earnings ratio of 25.20, a price-to-earnings-growth ratio of 4.82 and a beta of 1.55. Teradyne, Inc. has a 12 month low of $67.81 and a 12 month high of $127.29.
Teradyne (NASDAQ:TER – Get Rating) last posted its earnings results on Wednesday, January 25th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.75 by $0.17. Teradyne had a return on equity of 30.09% and a net margin of 22.68%. The firm had revenue of $731.84 million for the quarter, compared to analyst estimates of $711.84 million. During the same quarter in the prior year, the company earned $1.37 EPS. Teradyne’s revenue was down 17.3% on a year-over-year basis. On average, equities analysts anticipate that Teradyne, Inc. will post 2.97 earnings per share for the current year.
Teradyne Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, March 17th. Investors of record on Friday, February 17th were paid a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a yield of 0.41%. The ex-dividend date was Thursday, February 16th. Teradyne’s payout ratio is currently 10.43%.
Teradyne Profile
(Get Rating)
Teradyne, Inc engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, System Test, Robotics, Wireless Test, and Corporate. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services.
Further Reading
Receive News & Ratings for Teradyne Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Teradyne and related companies with MarketBeat.com’s FREE daily email newsletter.
